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Exercise can improve cognitive function and has
been linked to the increased expression of brain-
derived neurotrophic factor (BDNF). However, the
underlying molecular mechanisms driving the eleva-
tion of this neurotrophin remain unknown. Here we
show that FNDC5, a previously identified muscle
protein that is induced in exercise and is cleaved
and secreted as irisin, is also elevated by endurance
exercise in the hippocampus of mice. Neuronal
Fndc5 gene expression is regulated by PGC-1a,
and Pgc1a/mice show reduced Fndc5 expression
in the brain. Forced expression of FNDC5 in primary
cortical neurons increasesBdnf expression, whereas
RNAi-mediated knockdown of FNDC5 reduces
Bdnf. Importantly, peripheral delivery of FNDC5 to
the liver via adenoviral vectors, resulting in elevated
blood irisin, induces expression of Bdnf and other
neuroprotective genes in the hippocampus. Taken
together, our findings link endurance exercise and
the important metabolic mediators, PGC-1a and
FNDC5, with BDNF expression in the brain.
INTRODUCTION
Exercise, especially endurance exercise, is known to have
beneficial effects on brain health and cognitive function (Cotman
et al., 2007; Mattson, 2012a). This improvement in cognitive
function with exercise has been most prominently observed in
the aging population (Colcombe and Kramer, 2003). Exercise
has also been reported to ameliorate outcomes in neurological
diseases like depression, epilepsy, stroke, Alzheimer’s disease,
and Parkinson’s disease (Ahlskog, 2011; Arida et al., 2008;
Buchman et al., 2012; Russo-Neustadt et al., 1999; Zhang
et al., 2012). The effects of exercise on the brain are most
apparent in the hippocampus and its dentate gyrus, a part of
the brain involved in learning and memory. Specific beneficial
effects of exercise in the brain have been reported to include
increases in the size of and blood flow to the hippocampus in
humans, morphological changes in dendrites and dendritic
spines, increased synapse plasticity, and, importantly, de novo
neurogenesis in the dentate gyrus in various mouse models ofCell Mexercise (Cotman et al., 2007; Mattson, 2012a). De novo
neurogenesis in the adult brain has been observed in only two
areas; the dentate gyrus of the hippocampus is one of them,
and exercise is one of the few known stimuli of this de novo
neurogenesis (Kobilo et al., 2011).
One important molecular mediator for these beneficial re-
sponses in the brain to exercise is the induction of neurotro-
phins/growth factors, most notably brain-derived neurotrophic
factor (BDNF). In animal models, BDNF is induced in various
regions of the brain with exercise, most robustly in the hippo-
campus (Cotman et al., 2007). BDNF promotes many aspects
of brain development, including neuronal cell survival, differenti-
ation, migration, dendritic arborization, synaptogenesis, and
plasticity (Greenberg et al., 2009; Park and Poo, 2013). In
addition, BDNF is essential for synaptic plasticity, hippocampal
function, and learning (Kuipers and Bramham, 2006). High-
lighting the relevance of BDNF in human, individuals carrying
the Val66Met mutation in the BDNF gene exhibit decreased
secretion of BDNF, and display a decreased volume of specific
brain regions, deficits in episodic memory function, and
increased anxiety and depression (Egan et al., 2003; Hariri
et al., 2003). Blocking BDNF signaling with anti-TrkB antibodies
attenuates the exercise-induced improvement of acquisition and
retention in a spatial learning task, as well as the exercise-
induced expression of synaptic proteins (Vaynman et al., 2004,
2006). However, the underlying mechanism which induces
BDNF in exercise remains to be determined.
PGC-1a is induced by exercise in skeletal muscle, and is a
major mediator of the beneficial effects of exercise in this tissue
(Finck and Kelly, 2006). PGC-1a was initially discovered as a
transcriptional coactivator of mitochondrial biogenesis and
oxidative metabolism in brown fat (Puigserver et al., 1998; Spie-
gelman, 2007). Subsequent work has demonstrated an impor-
tant role of PGC-1a in the brain. Lack of PGC-1a in the brain is
associated with neurodegeneration (Lin et al., 2004; Ma et al.,
2010) as well as GABAergic dysfunction and a deficiency in
neuronal parvalbumin expression (Lucas et al., 2010). PGC-1a
has been shown to be neuroprotective in theMPTPmousemodel
of Parkinson’s disease (St-Pierre et al., 2006). It also negatively
regulates extrasynaptic N-methyl-D-aspartate (NMDA) receptor
activity and thereby reduces excitotoxicity in rat cortical neurons
(Puddifoot et al., 2012). In addition, the involvement of PGC-1 a
in the formation and maintenance of neuronal dendritic spines
has been reported (Cheng et al., 2012). Interestingly, long-term
forced treadmill running over 12 weeks increases Pgc1a ex-
pression in various areas of the brain (Steiner et al., 2011).etabolism 18, 649–659, November 5, 2013 ª2013 Elsevier Inc. 649
Figure 1. Endurance Exercise Induces Hip-
pocampal Fndc5 Gene Expression
(A–E) Male six-week-old C57/Bl6 wild-type mice
were individually housed in cages with access to
a running wheel (free running wheel) or without
(sedentary). Mice were exercised for 30 days
and sacrificed approximately 10 hr after their
last bout of exercise. Data are shown as mRNA
levels relative to Rsp18 expression, expressed as
mean ± SEM. *p < 0.05 compared to sedentary
control group. See also Figure S1.
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Exercise-Induced PGC-1a/FNDC5/BDNF PathwayRecently, our group identified a PGC-1a-dependent myokine,
FNDC5, that is cleaved and secreted from muscle during exer-
cise and induces some major metabolic benefits of exercise
(Bostrom et al., 2012). FNDC5 is a glycosylated type I membrane
protein and is released into the circulation after proteolytic
cleavage. The secreted form of FNDC5 contains 112 amino
acids and has been named irisin. Irisin acts preferentially on
the subcutaneous ‘‘beige’’ fat and causes it to ‘‘brown’’ by
increasing the expression of UCP-1 and other thermogenic
genes (Bostrom et al., 2012; Wu et al., 2012). Clinical studies in
humans have confirmed this positive correlation between
increased FNDC5 expression and circulating irisin with the level
of exercise performance (Huh et al., 2012; Lecker et al., 2012).
Interestingly, FNDC5 is also expressed in the brain (Dun et al.,
2013; Ferrer-Martinez et al., 2002; Teufel et al., 2002) and in
rat pheochromocytoma-derived PC12 cells differentiated into
neuron-like cells (Ostadsharif et al., 2011). Knockdown of
FNDC5 in neuronal precursors impaired the development into
mature neurons, suggesting a developmental role of FNDC5 in
neurons (Hashemi et al., 2013). This interesting connection of
FNDC5 as an important exercise-related factor in the periphery,
and its expression in the central nervous system, led us to
investigate the effects of exercise on FNDC5 expression and
function in the brain. Here we show that FNDC5 is elevated by
endurance exercise in the hippocampus of mice and that
PGC-1a and FNDC5 regulate BDNF expression in the brain.
RESULTS
Endurance Exercise Induces Hippocampal Fndc5
Gene Expression
FNDC5 is highly expressed in the brain, as well as in skeletal
muscle (Ferrer-Martinez et al., 2002; Teufel et al., 2002). Very
little is known about the function of FNDC5 in the brain.
We have therefore investigated the effects of exercise on
FNDC5 expression and function. We used an established650 Cell Metabolism 18, 649–659, November 5, 2013 ª2013 Elsevier Inc.endurance exercise regimen: 30 days of
voluntary free running-wheel exercise.
This regimen is known to induce
BDNF expression, neurogenesis, den-
dritic spines, and improved memory
function inmice (Eadie et al., 2005; Kobilo
et al., 2011). As has previously been
established, this training was sufficient
to induce muscle Fndc5 gene expression
(Figure 1A), as well as the transcriptionalregulators Pgc1a and Erra, known mediators of the exercise
response in skeletal muscle. In addition, other known genes of
the exercise gene program were induced, confirming an adap-
tive endurance exercise response in the muscle (see Figure S1
available online). Interestingly, the same exercise regime led to
a significant elevation of Fndc5 expression in the hippocampus
(Figure 1B), but not in the remainder of the brain (Figure 1C).
The hippocampus is a region of the brain involved in learning
and memory and has been identified as a major site where
changes occur that are induced by exercise. Of note, even
though genes that are induced by neuronal activity, such as
Arc, cFos, and Zif268, were upregulated in both the remainder
of the brain and the hippocampus, the important exercise-
related neurotrophin Bdnf was induced only in the hippo-
campus (Figures 1D and 1E). However, Npas4, an important
transcriptional component in hippocampal function and a key
regulator of activity-induced Bdnf expression (Lin et al., 2008;
Ramamoorthi et al., 2011), was not increased in the exercise
regimen used here (Figures 1D and 1E).These data suggest
that the induction of FNDC5 is part of the transcriptional
response to exercise in the hippocampus.
Fndc5 Gene Expression Correlates with Pgc1a
Expression Levels in Various Tissues
and Developmental Stages
Wepreviously reported that elevations in Fndc5 gene expression
in exercised muscle were dependent on PGC-1a (Bostrom et al.,
2012). We therefore investigated whether Fndc5 expression in
the brain is also regulated by PGC-1a. To first assess if there
is a correlation between the gene expression of these two
proteins, we isolated 13 different tissues from C57/Bl6 mice, ex-
tracted total RNA, and measured gene expression for Fndc5
and Pgc1a. Consistent with earlier reports, the highest level of
Fndc5 gene expression was detected in heart, skeletal muscle,
brain, and spinal cord (Ferrer-Martinez et al., 2002; Teufel et al.,
2002). When we grouped the different tissues according to their
Figure 2. Fndc5 Gene Expression Correlates with Pgc1a Expression Levels in Various Tissues and Developmental Stages
(A) The indicated tissues were harvested from male 13-week-old C57/Bl6 wild-type mice. Quad, quadriceps muscle; Gastroc, gastrocnemius muscle; Sp. Cord,
spinal cord; ingWAT, inguinal white adipose tissue; epiWAT, epididymal white adipose tissue; iBAT, interscapular brown adipose tissue.
(B) Brains were harvested from C57/Bl6 wild-type mice at the indicated postnatal (P) time points.
(C) Primary cortical neurons were isolated from C57/Bl6 wild-type E17 embryos and cultured for the indicated days in vitro. mRNA was prepared and
gene expression was assessed by qPCR. All data are shown as mRNA levels relative to Rsp18 expression, expressed as mean ± SEM. *p < 0.05 compared to
control group.
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Exercise-Induced PGC-1a/FNDC5/BDNF Pathwaylevels of Fndc5 expression, it is clear that most tissues with very
high Fndc5 expression also showed relatively high levels of
Pgc1a gene expression (Figure 2A). Notably, Fndc5 and Pgc1a
expression levels correlated well, even within very distinct mus-
cle beds. Fndc5 expression was higher in oxidative muscle,
such as the soleus muscle, which also contains higher levels of
Pgc1a, than in glycolytic or mixed muscles, such as gastrocne-
mius or quadriceps muscle. Exceptions to this tight correlation
of Fndc5 and Pgc1a expression are the interscapular brown ad-
ipose tissue and the kidney. Both are tissues with extremely high
mitochondrial content, which might explain their requirement
for high Pgc1a levels without very high expression of Fndc5.
To examine whether FNDC5 and PGC-1a were developmen-
tally regulated in synchrony during maturation of the brain, we
performed a time course experiment of postnatal development.
Brains were harvested from pups at postnatal day 0 (P0), P10,
P20, P25, and P30, and gene expression was measured by
qPCR. These time points were chosen because they cover
an important time period of postnatal brain developmental, up
to the mature state at P30. A two-step pattern of increased
Fndc5 gene expression during development was observed,
with a first increase between P0 and P10 and a second increase
between P10 and P20, which then leveled off (Figure 2B). Pgc1a
gene expression followed essentially the same pattern. Of note,
we also observed this two-step pattern of increased gene
expression during brain development for the key neural regu-
latory protein, Bdnf. Next, the gene expression patterns for
these factors were assessed during the maturation of primary
cortical neurons in culture. We observed again this correlation:
Fndc5 gene expression increased between in vitro day (DIV) 1
and DIV 6, when the expression levels of Pgc1a and Bdnf
were also elevated (Figure 2C). These data illustrate that, similar
to muscle, there is a strong correlation between PGC-1a and
FNDC5 gene expression in the brain.
Neuronal Fndc5 Gene Expression Is Regulated
by PGC-1a
To investigate whether PGC-1a is a transcriptional regulator of
Fndc5 gene expression in the brain, we turned to dissociatedCell Mprimary cortical neurons in culture. Although more heteroge-
neous than neurons from the dentate gyrus of the hippocam-
pus, these cultures can be isolated in sufficient quantities for
molecular studies and can be readily manipulated. Primary
cortical neurons were stimulated with forskolin (10 mM), a strong
inducer of intracellular cAMP, which is known to increase
Pgc1a gene expression in cell types as diverse as brown adipo-
cytes, hepatocytes, and Schwann cells (Cowell et al., 2008;
Herzig et al., 2001; Yoon et al., 2001). This increase in Pgc1a
gene expression was accompanied by a significant increase
in Fndc5 gene expression (Figure 3A). On the other hand, treat-
ment of cortical neurons with nifedipine (5 mM), a selective
L-type calcium channel blocker, which leads to decreased
intracellular calcium levels and decreased Pgc1a gene expres-
sion, was accompanied by decreased Fndc5 gene expression
(Figure 3B).
Next, genetic gain- and loss-of-function approaches were
used to test causality. Forced expression of PGC-1a by adeno-
viral delivery in primary cortical neurons resulted in a 4-fold
increased Fndc5 gene expression (Figure 3C). Immunoblotting
confirmed that the increase in Fndc5 mRNA translated into
elevated FNDC5 protein levels (Figure S2). Conversely, reducing
Pgc1a gene expression with lentiviral-mediated shRNA knock-
down by more than 40% significantly decreased Fndc5 gene
expression by 66% and 31%, respectively (Figure 3D). As an
additional loss-of-function model, the brains of global Pgc1a
knockout mice (Pgc1a/) were used. We observed the same
requirement of PGC-1a for Fndc5 gene expression in brains of
these mice, which display a reduction in Fndc5 gene expression
by 32% (Figure 3E). Taken together, these results demonstrate
that PGC-1a is a regulator of neuronal Fndc5 gene expression
in neural cultures and in the brain.
ERRa Is a Key Interacting Transcription Factor
with PGC-1a for Regulating Fndc5 Gene Expression
in Neurons
PGC-1a is a transcriptional coactivator, meaning it does not
bind to the DNA itself but interacts with transcription factors to
execute its effects on gene expression (Spiegelman, 2007).etabolism 18, 649–659, November 5, 2013 ª2013 Elsevier Inc. 651
Figure 3. Neuronal Fndc5 Gene Expression Is Regulated by a PGC-1a
(A) Primary cortical neurons at DIV 7 were treated overnight with either forskolin (10 mM), a stimulator of intracellular cAMP levels, or vehicle.
(B) Primary cortical neurons at DIV 7 were treated overnight with nifedipine (5 mM), an L-type calcium channel blocker, or vehicle.
(C) Primary cortical neurons at DIV 7 were transduced with either PGC-1a or GFP adenovirus and harvested 48 hr later.
(D) Primary cortical neurons at DIV 5 were transduced with lentivirus carrying the specified shRNA hairpins against Pgc1a or luciferase (Luc) as control and were
harvested 4 days later.
(E) Cortices were harvested from either male five-month-old Pgc1a KO (Pgc1a/) or wild-type mice (Pgc1a+/+).
mRNA was prepared and gene expression was assessed by qPCR. All data are shown as mRNA levels relative to Rsp18 expression, expressed as mean ± SEM.
*p < 0.05 compared to corresponding control group. See also Figure S2.
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Exercise-Induced PGC-1a/FNDC5/BDNF PathwayThe orphan nuclear receptor estrogen-related receptor alpha
(ERRa, also known as NR3B1) is a central metabolic regulator
(Gigue`re et al., 1988; Luo et al., 2003) and a very important
interactor with PGC-1a (Laganie`re et al., 2004; Mootha et al.,
2004; Schreiber et al., 2004). The interaction of Erra with
PGC-1a has been best studied in skeletal muscle, where it is
required for mitochondrial biogenesis, induction of angiogen-
esis, oxidative metabolism, and oxidative muscle fibers (Arany
et al., 2008; Mootha et al., 2004; Schreiber et al., 2004).
Interestingly, Erra follows the exercise-induced gene expres-
sion pattern of Fndc5 in the brain. Erra is upregulated in the
hippocampus upon exercise but not in the rest of the brain (Fig-
ures 1B and 1C). In addition, there was a correlation between
Fndc5 and Erra gene expression in our tissuevpanel (Figure 2A)
as well as our developmental time course (Figure 2B). PGC-1a
is well known to often increase the expression of transcription
factors that it interacts with, thereby positively regulating its
own regulators (Handschin et al., 2003; Mootha et al., 2004).
We therefore asked if forced expression of PGC-1a in primary
cortical neurons results in an increase in Erra mRNA. Indeed,
adenoviral expression of PGC-1a significantly increased Erra
gene expression, but not Errb or Errg gene expression (Fig-
ure 4A). However, mRNA for other common binding partners652 Cell Metabolism 18, 649–659, November 5, 2013 ª2013 Elsevierof PGC-1a, such as Mef2, Ppara, Nrf1, or Gabpa/b, was not
induced in these experiments (Figure S3A).
ThemurineFndc5geneand6 kbof its upstreampromoterwere
searched for putative ERRa transcription factor binding sites
(ERREs)with the canonical ‘‘TGACCTT’’ sequence (Charest-Mar-
cotte et al., 2010; Mootha et al., 2004; Wang et al., 2012). We
identified two putative ERREs: one around 5.3 kb upstream of
the transcriptional start site and one in the fourth intron of the
Fndc5 gene (Figure 4B). ERRa had been previously reported to
also bind to intronic sequences to exert its biological function
(Arany et al., 2008). This further suggests that ERRa could be
important in FNDC5 gene regulation. Treatment of primary
cortical neurons with XCT 790 (1 mM), a selective ERRa inhibitor
(inverseagonist)whichdisrupts theERRa/PGC-1a transcriptional
complex (Mootha et al., 2004), significantly reduced Fndc5 gene
expression compared to vehicle-treated cells (Figure 4C). How-
ever, stimulation with DY131 (1 mM), a selective ERRb and
ERRg agonist, had no effect on Fndc5 gene expression. This sug-
gests certain specificity for the involvement of ERRa compared
to other ERR subfamily members. Since the nuclear receptor
PPARa, another commonbinding partner of PGC-1a, was slightly
induced by forced expression of PGC-1a, we tested the effect
of GW7647, a potent and highly selective PPARa agonist, andInc.
Figure 4. ERRa Is a Key Interacting Transcription Factor with PGC-1a for Regulating Fndc5 Gene Expression in Neurons
(A) Primary cortical neurons at DIV 7 were transduced with either PGC-1a or GFP adenovirus and harvested 48 hr later. *p < 0.05 compared to control group.
(B) Primary cortical neurons at DIV 7 were treated overnight with either XCT 790 (1 mM), a selective inverse ERRa agonist, DY131 (1 mM), a selective ERRb and
ERRg agonist, or vehicle. *p < 0.05 compared to vehicle only group.
(C) Primary cortical neurons at DIV 4 were transduced with lentivirus carrying shRNA hairpins against either Erra or luciferase (Luc) as control. Three days later,
cells were transduced with either PGC-1a or GFP adenovirus and then harvested 48 hr later.
(D) Analysis of the murine Fndc5 promoter for putative ERREs. The murine Fndc5 gene and 6 kb of its upstream promoter were searched for the canonical ERRE:
TGACCTT. Genomic coordinates are given according to the assembly mm9 from the UCSC Genome Browser. The bottom diagram indicates the degree of
mammalian conservation across the genomic locus. The presented motif was modified from http://www.factorbook.org/ (Wang et al., 2012). See also Figure S3.
mRNA was prepared and gene expression was assessed by qPCR. Data are shown as mRNA levels relative to Rsp18 expression, expressed as mean ± SEM.
*p < 0.05 compared to corresponding shLuc expressing control group. $p < 0.05 compared to corresponding GFP expressing control group. Data in (A)–(C) are
shown as mRNA levels relative to Rsp18 expression, expressed as mean ± SEM.
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Exercise-Induced PGC-1a/FNDC5/BDNF PathwayGW0742, a potent and highly selective PPARd agonist on
Fndc5 gene expression. However, under the conditions tested,
no effect on Fndc5 gene expression in primary cortical neurons
by these compounds was observed (Figure S3B).
The results from the treatment with ERRa antagonist suggest
that interaction of the PGC-1a with ERRa is required for the
PGC-1a-dependent induction of Fndc5 gene expression. To
test this, we first knocked down ERRa in primary cortical neurons
using lentivirally expressed shRNA hairpins and then 3 days
later transduced the cells with either the PGC-1a adenovirus or
GFP expressing adenovirus. ErramRNA was efficiently knocked
down by this hairpin (70%), and forced expression of PGC-1 a
did not affect the efficiency of the knockdown (Figure S2C).
Knockdown of ERRa significantly reduced Fndc5 gene expres-
sion at baseline (Figure 4D). Furthermore, forced expression of
PGC-1a by adenovirus in the cells with reduced ERRa failed to
significantly increase Fndc5 gene expression (Figure 4D). How-
ever, this failure to increase Fndc5 gene expression was not
due to a lack of overexpression of PGC-1a in the shErra-treated
neurons (Figure S3C). Together these data suggest an involve-
ment of ERRa in the induction of FNDC5 by PGC-1a. The precise
role of the individual ERRa binding sites in the Fndc5 gene
remains to be determined.
FNDC5 Regulates Bdnf Gene Expression in a
Cell-Autonomous Manner, and Recombinant
BDNF Decreases Fndc5 Gene Expression
as Part of a Potential Feedback Loop
As mentioned earlier, BDNF is a major mediator of certain bene-
ficial effects on the brain. In addition, an increase in the BdnfCell Mgene expression in the hippocampus was observed, where
Fndc5 gene expression was also induced (Figures 1B and 1D),
but not in the rest of the brain, where Fndc5 was not induced
(Figures 1C and 1E). We therefore tested whether FNDC5 could
be a regulator of Bdnf gene expression in a cell-culture model.
Primary cortical neurons were transduced with either FNDC5
adenovirus or a GFP adenovirus as control. Forced expression
of FNDC5 resulted in a clear increase in FNDC5 protein in the
whole-cell lysate, as well as an increase in the secreted form of
FNDC5 (irisin) in the cell-culture supernatant (Figure 5A). After
deglycosylation, this protein has the same apparent molecular
mass (12 kDa) as that predicted for irisin (Figure 5A). In addition,
forced expression of FNDC5 significantly upregulated Bdnf
gene expression by 4-fold (Figure 5B). Importantly, FNDC5
expression also induced other important activity-induced genes
involved in hippocampal function, including Npas4, cFos, and
Arc; Zif268, however, was only slightly elevated.
To investigate if FNDC5 is required for Bdnf gene expression,
lentivirally delivered shRNA was used to knock down FNDC5 in
primary cortical neurons. To address possible off-targets of
a single hairpin, we tested a total of five hairpins, three of which
significantly knocked down Fndc5mRNA (Figure 5C). The same
three hairpins also significantly reduced Bdnf gene expression.
We also assessed the role of PGC-1a in controlling Bdnf gene
expression in vivo. To do this, we used the brains of global
Pgc1a knockout mice (Pgc1a/). As shown in Figure 3E, Bdnf
gene expression was significantly reduced in the brains of
Pgc1a/ mice (Figure 3E).
BDNF is well known for its ability to improve survival
of neurons in culture. We therefore assessed the effects ofetabolism 18, 649–659, November 5, 2013 ª2013 Elsevier Inc. 653
Figure 5. FNDC5 Regulates Bdnf Gene Expression in a Cell-Autonomous Manner, and Recombinant BDNF Decreases Fndc5 Gene
Expression as Part of a Negative Feedback Loop
(A) Primary cortical neurons at DIV 6 were transduced with either FNDC5 or GFP adenovirus. Whole-cell lysates and conditioned media were harvested and
analyzed by immunoblotting. Intensity of unspecific bands and Ponceau staining were used to assess equal loading. deglyc., deglycosylation.
(B) Primary cortical neurons at DIV 7 were transduced with either FNDC5 or GFP adenovirus. Forty-eight hours later mRNA was prepared and gene expression
was assessed by qPCR.
(C) Primary cortical neurons at DIV 5 were transduced with lentivirus carrying the specified shRNA hairpins against Fndc5 or luciferase (Luc) as control. Four days
later, mRNA was prepared and gene expression was assessed by qPCR.
(D) Primary cortical neurons at DIV 7 were transduced with either FNDC5 or GFP adenovirus. Cell viability was assessed 3 days later using the CellTiter-Glo
Luminescent Cell Viability Assay. AU, arbitrary unit.
(E) Primary cortical neurons at DIV 5 were transduced with lentivirus carrying the specified shRNA hairpins against Fndc5 or luciferase (Luc) as control. Cell
viability was assessed 3 days later using the CellTiter-Glo Luminescent Cell Viability Assay. AU, arbitrary unit.
(F) Primary cortical neurons at DIV 7were stimulated overnight with the indicated recombinant neurotrophins and growth factors (100 ng/ml). mRNAwas prepared
and gene expression was assessed by qPCR.
(G) Primary cortical neurons at DIV 7 were stimulated overnight with human recombinant BDNF at the indicated concentrations or vehicle. mRNA was prepared
and gene expression was assessed by qPCR.
(H) Primary cortical neurons at DIV 6 were treated either with the TrkB inhibitor K252a (50 nM) or vehicle. Twenty-four hours later, human recombinant
BDNF (100 ng/ml) or vehicle was added for overnight stimulation. mRNA was prepared and gene expression was assessed by qPCR.
Data (B, C, and F–H) are shown as mRNA levels relative to Rsp18 expression. All data are expressed as mean ± SEM. *p < 0.05 compared to corresponding
control group.
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Exercise-Induced PGC-1a/FNDC5/BDNF Pathwaygain- and loss-of-function of FNDC5 on cell viability of cultured
neurons using a luminescence/ATP-based assay. Gain of
function of FNDC5 significantly improved neuron survival in
culture (Figure 5D), while loss of function of FNDC5 using
shRNA-mediated knockdown of FNDC5 with two different
hairpins significantly impaired the survival of neurons in culture
(Figure 5E).654 Cell Metabolism 18, 649–659, November 5, 2013 ª2013 ElsevierTo examine how BDNF might, in turn, alter FNDC5 gene
expression, primary cortical neurons were stimulated overnight
with recombinant BDNF at various concentrations at physio-
logical and pharmacological dosages (0.1–100 ng/ml). BDNF
concentrations as low as 1 ng/ml significantly reduced
Fndc5 gene expression (Figure 5F), and a dose response
was observed. To ask whether the reduction in Fndc5 geneInc.
Figure 6. Peripheral Delivery of FNDC5 by
Adenoviral Vectors Increases Bdnf Expres-
sion in the Hippocampus
(A–C) Five-week-old male wild-type BALB/c mice
were intravenously injected with GFP- or FNDC5-
expressing adenoviral particles. Animals were
sacrificed 7 days later; (A) inguinal/subcutaneous
fat pads (WAT, white adipose tissues), (B) hippo-
campus, and (C) forebrain were collected; and
mRNA was prepared and gene expression was
assessed by qPCR. Data are shown as mRNA
levels relative to Rsp18 expression, expressed as
mean ± SEM. *p < 0.05 compared to wild-type
control group.
(D) Model of the hippocampal PGC-1a/FNDC5/
BDNF pathway in exercise. Endurance exercise
stimulates increased hippocampal Fndc5 gene
expression through a PGC-1a/Erra transcriptional
complex. This elevated Fndc5 gene expression in
turn stimulates Bdnf gene expression. BDNF is
the master regulator of nerve cell survival, differ-
entiation, and plasticity in the brain. This will
lead to improved cognitive function, learning, and
memory, which are known beneficial effects of
exercise on the brain. See also Figure S4.
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neurons with a variety of central and peripheral neurotrophic
factors in addition to BDNF, such as ciliary neurotrophic factor
(CNTF), glial cell-derived neurotrophic factor (GDNF), nerve
growth factor (NGF), and insulin-like growth factor 1 (IGF-1), at
100 ng/ml overnight. However, only BDNF stimulation signifi-
cantly reduced Fndc5 mRNA expression Figure 5G). This effect
was abolished by preincubating the cortical neurons with a low
dose (50 nM) of K252a, well-characterized inhibitor of TrkB,
the receptor of BDNF signaling (Gime´nez-Cassina et al., 2012;
Tapley et al., 1992) (Figure 5H). In summary, these data suggest
a homeostatic FNDC5/BDNF feedback loop.
Peripheral Delivery of FNDC5 by Adenoviral Vectors
Increases Bdnf Expression in the Hippocampus
We had previously shown that adenoviral overexpression of
FNDC5 in the liver, amajor secretory organ, increases circulating
levels of irisin, the secreted form of FNDC5 (Bostrom et al., 2012).
This resulted in the activation of a thermogenic gene program
in certain fat tissues. To determine if peripheral delivery of
FNDC5/irisin could elevate central BDNF levels, we repeated
this experiment and measured Bdnf gene expression in the
hippocampus 7 days later. As previously reported, forced
expression of FNDC5 in the liver in the induced ‘‘browning’’ of
the inguinal fat depot (Figure 6A) was shown by increased
expression of mRNA for a group of key thermogenic genes,
such as Pgc1a, Ucp1, and Cidea. In addition, plasma levels of
irisin were elevated in mice overexpressing FNDC5 as com-
pared to GFP-overexpressing control mice (Figure S4A). Inter-
estingly, Bdnf expression in the hippocampus was significantly
increased, as was expression of Npas4, cFos, Arc, and Zif268,
all part of the activity-induced immediate-early gene (IEG) pro-
gram, as mentioned before. Importantly, this was not caused
by any viral mediated expression of Fndc5 in the brain orCell Mhippocampus (Figure 6B), strongly suggesting that the secreted
form of the peripherally expressed FNDC5 was responsible for
this effect. This effect of increased Bdnf expression was specific
to the hippocampus, since it was not observed in the forebrain
(Figure 6C), whereas the IEG response was observed in both;
this is consistent with our earlier findings of the effects of exer-
cise (Figures 1D and 1E).
PGC-1a/FNDC5/BDNF Pathway in Primary Hippocampal
Neurons
We used cortical neurons in the experiments above because
this is the most widely used system of primary CNS cultures
and because reasonable numbers of cells can be obtained.
However, since some of our observations in vivo were made in
the hippocampus, we sought to validate our findings in primary
hippocampal neurons. Therefore, a key set of experiments
were repeated in primary hippocampal neuron cultures. We
confirmed that Fndc5 gene expression is significantly increased
in primary hippocampal neurons cultured in vitro from DIV 1 to
DIV 6; the expression of Pgc1a and the expression of Bdnf
mRNA are similarly increased (Figure 7A). To test whether
PGC-1a regulates Fndc5 gene expression in hippocampal
neurons, gain- and loss-of-function studies were performed.
Forced expression of PGC-1a significantly induced Fndc5
gene expression (Figure 7B). Interestingly, stimulation with
forskolin (10 mM) failed to induce Pgc1a gene expression but
decreased the expression of Erra and Fndc5 (Figure S5). Efficient
knockdown of Pgc1a by lentivirally delivered shRNA signifi-
cantly reduced Fndc5 gene expression (Figure 7C). Stimulation
of primary hippocampal neurons with commercially available
recombinant irisin induced a similar gene program (Arc, cFos,
Npas4, and Zif268) as was found in the in vivo adenoviral ex-
periments (Figure 7D). However, the increase in Bdnf gene
expression did not reach statistical significance. Loss of functionetabolism 18, 649–659, November 5, 2013 ª2013 Elsevier Inc. 655
Figure 7. PGC-1a/FNDC5/BDNF Pathway in Primary Hippocampal Neurons
(A) Primary hippocampal neurons were isolated from C57/Bl6 wild-type E17 embryos and cultured for the indicated days in vitro.
(B) Primary hippocampal neurons at DIV 7 were transduced with either PGC-1a or GFP adenovirus and harvested 48 hr later.
(C) Primary hippocampal neurons at DIV 5 were transduced with lentivirus carrying the specified shRNA hairpin against Pgc1a or luciferase (Luc) as control and
harvested 4 days later.
(D) Primary hippocampal neurons were stimulated with recombinant irisin (1 mg/ml) at DIV 5 and DIV 6 and harvested 24 hr later.
(E) Primary hippocampal neurons at DIV 5 were transduced with lentivirus carrying the specified shRNA hairpins against Fndc5 or luciferase (Luc) as control
and harvested 4 days later.
(F) Primary hippocampal neurons at DIV 7 were stimulated overnight with recombinant BDNF (100 ng/ml).
mRNA was prepared and gene expression was assessed by qPCR. Data are shown as mRNA levels relative to Rsp18 expression, expressed as mean ± SEM.
*p < 0.05 compared to corresponding control group. See also Figure S5.
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hairpins against Fndc5 significantly reduced Bdnf gene ex-
pression in hippocampal neurons (Figure 7E). In addition,
treatment of hippocampal neurons with recombinant BDNF
reduced Fndc5 gene expression (Figure 7F). Together, these
data demonstrate that the basic observations made in the
primary cortical neurons also apply to primary hippocampal
neuron cultures.
DISCUSSION
A recent study has reported a positive correlation between hu-
man brain size and endurance exercise capacity, suggesting
a coevolution between human cognition and locomotion (Rai-
chlen and Gordon, 2011). More complex tasks require a more
complex brain, and foraging in wide and open spaces in the
savannas put high demands on spatial orientation, as well as
the ability to acquire and retain new information. Therefore
individuals with a more complex brain who performed better
at these tasks might have had an evolutionary advantage. On
the other hand, since endurance exercise clearly increases
expression of BDNF in the brain, improvements in the exercise
capacity might have positively enforced brain growth (Mattson,
2012b), especially in the hippocampus.656 Cell Metabolism 18, 649–659, November 5, 2013 ª2013 ElsevierIn this study we report a PGC-1a/FNDC5/BDNF pathway that
is activated in the hippocampus by endurance exercise (Fig-
ure 6). In our current model, exercise leads to increased tran-
scription of Pgc1a and Erra. It has been observed previously
that PGC-1a often induces the expression of transcription
factors to which it binds and which it coactivates (Handschin
et al., 2003; Mootha et al., 2004). Indeed, the ability of PGC-1a
to induce FNDC5 gene expression depends on ERRa availability
(Figure 4D). This PGC-1a/Erra complex, in turn, may bind to
one or more of the canonical ERREs found in or near the
Fndc5 gene, thus activating Fndc5 gene expression. As shown
in a cell-culture model in Figure 5A, FNDC5 is a positive regulator
of BDNF expression. Based on this, it seems likely that
the increased Fndc5 gene expression in exercise will lead to
increased BDNF levels. Interestingly, BDNF also can signal
to reduce the expression of FNDC5 as part of an apparent ho-
meostatic loop. Both FNDC5-dependent and FNDC5-indepen-
dent pathways by which exercise induces BDNF expression
seem plausible. For example, CREB and NF-kB are two other
transcription factors known to induce BDNF expression in exer-
cise (Mattson, 2012b). These may act upstream or downstream
of FNDC5, or in an independent pathway.
The induction of FNDC5 by exercise in the hippocampus is
quantitatively comparable to the induction observed in skeletalInc.
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the induction of BDNF, a neurotrophic mediator of exercise in
the brain, as well as cFOS, ARC, and ZIF268, important indica-
tors for the activity state of neurons (Hunt et al., 1987; Lyford
et al., 1995; Rusak et al., 1990; Saffen et al., 1988). This places
FNDC5 induction in a similar range to other known important
regulators in the brain.
In our study of 30 days of free running-wheel exercise, Fndc5
and Pgc1a were induced in the hippocampus, but not in the rest
of the brain (Figure 1B) when taken as one unit. Therefore it is
possible that Fndc5 and Pgc1a were induced in relatively small
numbers of neurons elsewhere, but that that change was not
detectable because it is occurring in the background of little or
no change in larger brain structures. Indeed, using a longer
and more intense exercise regimen exercise protocol and
more detailed dissections, Steiner et al. reported an upregulation
of Pgc1a expression in various other parts of the brain, in
addition to the hippocampus (Steiner et al., 2011).
A central question arising from our study is this: How does the
PGC-1a/FNDC5/BDNF pathway get initiated in exercise? This
question is closely linked to the more central and open question
in the field: How is exercise sensed by the brain? One obvious
initiator could be increased neuronal activity in areas of the
brain that are involved in spatial orientation, learning, and mem-
ory, since BDNF gene expression is well known to be stimulated
by neural activity (West and Greenberg, 2011). Increased
sympathetic tone, namely higher norepinephrine levels (Garcia
et al., 2003), and increased IGF-1 levels from periphery crossing
the blood-brain barrier have also been discussed as exercise-
related inducers of BDNF (Ding et al., 2006). However, because
exercise is known to change the metabolic state of the whole
body, another important factor could be changes in the energy
state or oxygen levels within the brain, both signals to which
Pgc1a gene expression is known to respond in other tissues
(Arany et al., 2008; St-Pierre et al., 2006). In our study we linked
the activation of a metabolic regulator, PGC-1a, via FNDC5 to
increased BDNF levels in the neurons in response to exercise
(Figure 6). Of note, there are other important metabolic regula-
tors, such as AMPK or PPARgamma, which have not been part
of this study.
FNDC5 in the periphery is cleaved and secreted as irisin, and
secreted irisin can cause the ‘‘browning’’ of adipose tissues
(Bostrom et al., 2012; Shan et al., 2013; Wu et al., 2012). There-
fore several important questions arise from our studies. First,
is FNDC5 functioning mainly as a membrane-bound molecule
in the brain, or is it secreted by neurons? Second, if FNDC5 is
secreted, is it secreted as irisin (amino acids 29–140) or as
a different peptide species? Perhaps the most exciting result
overall is that peripheral delivery of FNDC5 with adenoviral
vectors is sufficient to induce central expression of Bdnf and
others genes with potential neuroprotective functions or those
involved in learning and memory. This suggests that a secreted,
circulating form of FNDC5 has these effects on these neurons
and that it crosses the blood-brain barrier. Whether this is the
full-length irisin protein or a further modified form remains to
be determined. The therapeutic implications of this are obvious,
since the data suggest that a polypeptide might be developed
as a drug capable of giving neuroprotection in disease states
or improved cognition in aging populations.Cell MEXPERIMENTAL PROCEDURES
Reagents
Recombinant human BDNF was purchased from PeproTech, recombinant
human GDNF and CNTF and forskolin were purchased from Sigma, and
recombinant mouse IGF-1 was obtained from R&D Systems. Recombinant
mouse NGF and K252a were obtained from EMD Millipore. Nifedipine, XCT
790, DY131, GW7647, and GW0742 were purchased from Tocris. Recombi-
nant irisin (human, rat, mouse, canine) was obtained from Phoenix Pharma-
ceuticals (Burlingame).
Primers Used for qPCR
All primers used are listed with their sequences in Table S1.
Animal Studies
All animal experiments were performed according to procedures approved
by the IACUC of Dana-Farber Cancer Institute and the BIDMC. Pgc1a/
mice have been described previously (Lin et al., 2004). Mice were housed
and exercised as previously described (Bostrom et al., 2012).
Cell Culture
Primary cortical and hippocampal neurons were isolated as described previ-
ously (Bartlett and Banker, 1984).
RNA and Protein Preparation and Analysis
RNA and protein analyses were performed as described previously (Bostrom
et al., 2012).
Forced Expression and Knockdown of Target Genes
Generation and delivery of PGC-1a, GFP, and FNDC5 adenovirus have
been described before (Bostrom et al., 2012; Lustig et al., 2011). For knock-
down studies, primary cortical neurons were transduced with lentiviral viral
supernatants.
Cell Viability Assay
Cell viability of cultured neurons was assessed by using CellTiter-Glo
Luminescent Cell Viability Assay (Promega, Madison) according to the
manufacturer’s instructions.
Analysis of theMurine Fndc5Promoter for Erra Transcription Factor
Binding Sites
The genomic sequence of themurine Fndc5 gene and 6 kb of its upstream pro-
moter was retrieved from the USCS Genome browser (http://www.genome.
ucsc.edu/; assembly mm9). This genomic sequence was searched for the
canonical Erra transcription factor binding motif TGACCTT. This motif had
been identified and established in previous studies (Charest-Marcotte et al.,
2010; Mootha et al., 2004; Wang et al., 2012).
Peripheral Delivery of FNDC5 by Adenoviral Vectors
High-titer GFP- or FNDC5-expressing adenoviral particles were obtained by
ViraQuest Inc. (North Liberty, IA). Five-week-old male wild-type BALB/c
mice were injected with GFP- or FNDC5-expressing adenoviral particles
(1011/animal) intravenously. Animals were sacrificed 7 days later, and the indi-
cated tissues were harvested for gene expression analyses using qPCR.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.cmet.2013.09.008.
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